Linda Su-Feher

5PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 14, 2026
Evaluation of Biomarkers for Sacituzumab Govitecan in Metastatic Non-Small Cell Lung Cancer: Insights From the EVOKE-01 Study.

|Aug 30, 2024
Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial.

Amitkumar Mehta, Leslie Popplewell, Graham P Collins

|Apr 04, 2022
Single cell enhancer activity distinguishes GABAergic and cholinergic lineages in embryonic mouse basal ganglia.

Linda Su-Feher, Anna N Rubin, Shanni N Silberberg

|Oct 04, 2021
Parallel functional testing identifies enhancers active in early postnatal mouse brain.

Jason T Lambert, Linda Su-Feher, Karol Cichewicz

|Jul 04, 2017
Germline Chd8 haploinsufficiency alters brain development in mouse.

Andrea L Gompers, Linda Su-Feher, Jacob Ellegood

Pageof 1

Frequent Collaborators

3 joint publications

Alex S Nord

2 joint publications

Rinaldo Catta-Preta

2 joint publications

Iva Zdilar

1 joint publications

A Ayanna Wade